3 01/01/2024 31/12/2024 2024-12-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-01-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 11666213 2024-01-01 2024-12-31 11666213 2024-12-31 11666213 2023-12-31 11666213 2023-01-01 2023-12-31 11666213 2023-12-31 11666213 2022-12-31 11666213 bus:Director1 2024-01-01 2024-12-31 11666213 core:WithinOneYear 2024-12-31 11666213 core:WithinOneYear 2023-12-31 11666213 bus:Micro-entities 2024-01-01 2024-12-31 11666213 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 11666213 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11666213 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11666213 bus:FullAccounts 2024-01-01 2024-12-31
Company registration number: 11666213
AMPM Pharma Limited
Unaudited filleted financial statements
31 December 2024
AMPM Pharma Limited
Contents
Statement of financial position and notes to the financial statements
AMPM Pharma Limited
Statement of financial position
31 December 2024
2024 2023
£ £ £ £
Fixed assets 2,843 1,585
_______ _______
Current assets 383,428 274,842
Prepayments and accrued income 200 200
_______ _______
383,628 275,042
Creditors: amounts falling due within one year ( 302,676) ( 213,379)
_______ _______
Net current assets 80,952 61,663
_______ _______
Total assets less current liabilities 83,795 63,248
Accruals and deferred income ( 3,000) ( 3,192)
_______ _______
Net assets 80,795 60,056
_______ _______
Capital and reserves 80,795 60,056
_______ _______
Notes to the financial statements
AMPM Pharma Limited
Year ended 31 December 2024
1. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2023: 3 ).
2. Going Concern
In accordance with their responsibilities as directors, the directors have considered the appropriateness of the going concern basis for the preparation of the financial statements. The directors have reviewed the impact of the macro-economic uncertainties on the company and consider that these are not expected to affect the company. Accordingly, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The member has not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 05 November 2025 , and are signed on behalf of the board by:
Priyanka Mehta
Director
Company registration number: 11666213
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Scottish Provident House, 3rd floor, 76-80 College Road, Harrow, Middlesex, HA1 1BQ.